WHO, Partners Launch Malaria Vaccine Technology Roadmap

“The [WHO] and its partners Thursday announced a new goal to license vaccines by 2030 that would sharply reduce malaria cases and eventually eliminate the disease,” VOA News reports (DeCapua, 11/14). The updated 2013 Malaria Vaccine Technology Roadmap “comes in addition to the original 2006 roadmap’s goal of having a licensed vaccine against Plasmodium falciparum malaria, the most deadly form of the disease, for children under five years of age in sub-Saharan Africa by 2015,” a press release from the WHO states (11/14). “[T]he new [roadmap] raises the bar by setting two strategic goals: having vaccines in place by 2030 that can help achieve malaria elimination in multiple settings and having vaccines that are highly effective against the disease,” CIDRAP News writes (Schnirring, 11/14). “To meet the goals, the document sets out a number of priority areas to be addressed, including ensuring results of funded clinical trials are publicly-available within 12 months, and establishing a systematic approach for [prioritizing] vaccine candidates,” SciDevNet adds (Winston, 11/14).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.